| | ISVH Society News ISVH – A multi-disciplinary society Vasc Health Risk Manag. 2006 December; 2(4): 325–326. Published online 2006 December. PMCID: PMC1994010 Reviews Olmesartan medoxomil: current status of its use in monotherapy Hans R Brunner Vasc Health Risk Manag. 2006 December; 2(4): 327–340. Published online 2006 December. PMCID: PMC1994016 Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data Claudio Borghi and Arrigo FG Cicero Vasc Health Risk Manag. 2006 December; 2(4): 341–349. Published online 2006 December. PMCID: PMC1994025 Management of cancer-associated venous thrombosis Ozlem Er and Leo Zacharski Vasc Health Risk Manag. 2006 December; 2(4): 351–356. Published online 2006 December. PMCID: PMC1994007 Bivalirudin in percutaneous coronary intervention Sam J Lehman and Derek P Chew Vasc Health Risk Manag. 2006 December; 2(4): 357–363. Published online 2006 December. PMCID: PMC1994003 Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery David Bergqvist Vasc Health Risk Manag. 2006 December; 2(4): 365–370. Published online 2006 December. PMCID: PMC1994024 Fondaparinux in the management of patients with ST-elevation acute myocardial infarction Alexander GG Turpie Vasc Health Risk Manag. 2006 December; 2(4): 371–378. Published online 2006 December. PMCID: PMC1994017 Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI) Huyen Tran, Shamir R Mehta, and John W Eikelboom Vasc Health Risk Manag. 2006 December; 2(4): 379–387. Published online 2006 December. PMCID: PMC1994022 A review of levosimendan in the treatment of heart failure Hulya Akhan Kasikcioglu and Nese Cam Vasc Health Risk Manag. 2006 December; 2(4): 389–400. Published online 2006 December. PMCID: PMC1994023 Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension Mark Greathouse Vasc Health Risk Manag. 2006 December; 2(4): 401–409. Published online 2006 December. PMCID: PMC1994014 Sildenafil in the treatment of pulmonary hypertension Christopher F Barnett and Roberto F Machado Vasc Health Risk Manag. 2006 December; 2(4): 411–422. Published online 2006 December. PMCID: PMC1994020 Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure Melvin R Echols and Clyde W Yancy Vasc Health Risk Manag. 2006 December; 2(4): 423–431. Published online 2006 December. PMCID: PMC1994006 Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients Heng Joo Ng and Lai Heng Lee Vasc Health Risk Manag. 2006 December; 2(4): 433–440. Published online 2006 December. PMCID: PMC1994012 Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter? JV (Ian) Nixon Vasc Health Risk Manag. 2006 December; 2(4): 441–446. Published online 2006 December. PMCID: PMC1994009 Sexual function in hypertensive patients receiving treatment Thorsten Reffelmann and Robert A Kloner Vasc Health Risk Manag. 2006 December; 2(4): 447–455. Published online 2006 December. PMCID: PMC1994005 The impact of health literacy on cardiovascular disease Richard S Safeer, Catherine E Cooke, and Jann Keenan Vasc Health Risk Manag. 2006 December; 2(4): 457–464. Published online 2006 December. PMCID: PMC1994011 Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment Leila Fernandes Araujo, Alexandre de Matos Soeiro, Juliano Lara Fernandes, Antônio Eduardo Pesaro, and Carlos V Serrano, Jr Vasc Health Risk Manag. 2006 December; 2(4): 465–475. Published online 2006 December. PMCID: PMC1994008 Outcomes of coronary artery bypass graft surgery Anna Louise Hawkes, Madeleine Nowak, Benjamin Bidstrup, and Richard Speare Vasc Health Risk Manag. 2006 December; 2(4): 477–484. Published online 2006 December. PMCID: PMC1994021 Original Research Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophyand arterial stiffening in hypertensive subjects Liliana Legedz, Giampiero Bricca, Pierre Lantelme, Marie-Odile Rial, Pierre Champomier, Madeleine Vincent, and Hugues Milon Vasc Health Risk Manag. 2006 December; 2(4): 485–490. Published online 2006 December. PMCID: PMC1994018 Assessment of cognitive function in patients with essential hypertension treated with lercanidipine J Tisaire-Sánchez, J Roma, Ignacio CamachoAzcargorta, J Bueno-Gómez, J Mora-Maciá, and Angel Navarro Vasc Health Risk Manag. 2006 December; 2(4): 491–498. Published online 2006 December. PMCID: PMC1994004 Hypothyroidism in coronary heart disease and its relation to selected risk factors Otto Mayer, Jr, Jaroslav Šimon, Jan Filipovský, Markéta Plášková, and Richard Pikner Vasc Health Risk Manag. 2006 December; 2(4): 499–506. Published online 2006 December. PMCID: PMC1994013 Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, and Maria Carla Roncaglioni Vasc Health Risk Manag. 2006 December; 2(4): 507–514. Published online 2006 December. PMCID: PMC1994019 Erratum Vasc Health Risk Manag. 2006 December; 2(4): 515. Published online 2006 December. PMCID: PMC1994015 Corrects: Roland Asmar, et al. A Large Scale Study of Angiotensin II Inhibition Therapy in an Elderly Population: the Chance Study. Vasc Health Risk Manag. 2006 September; 2(3): 317–323. |